The latest in pacing: leadless dual-chamber pacemaker
A study on the first experience with transcatheter implantation of a leadless dual-chamber pacemaker in humans.
The Radial Artery, the Best Companion for Double Internal Mammary Artery
A systematic review and meta-analysis of observational studies comparing the use of double internal mammary artery (BITA) with saphenous vein (SV) versus BITA with radial artery (RA) in surgical treatment for triple-vessel coronary artery disease. Long-term survival was evaluated with follow-up up to 12 years.
Valve Bioprostheses: Resilient Over Time
Five-Year Results and Preliminary Seven-Year Data from the COMMENCE Study on Edwards® RESILIA® Bovine Pericardial Tissue in Aortic Position Bioprostheses
Surgical Implantation of Balloon-Expandable Valve Prosthesis in Cases of Severe Mitral Annular Calcification: Another Tool in the Armamentarium
An analysis of the technique and outcomes of the largest published series on the surgical implantation of balloon-expandable valves (Sapien) in patients with severe mitral annular calcification (MAC).
Clinical practice guidelines: a awaiting challenge in pediatric cardiac surgery
Experience of an American center implementing clinical practice guidelines for the surgical repair of ventricular septal defect.
Aortic valve preservation: is it the same in children as in adults?
A retrospective study from the Royal Children’s Hospital (Melbourne, Australia) analyzing long-term outcomes of aortic root surgery with valve preservation.
Long-Term Ventricular Assist in Spain (REGALAD Registry): Consolidation of an Unstoppable and Rising Reality
This study offers the first detailed analysis of the Spanish registry for long-term ventricular assist devices (REGALAD), encompassing all patients who received these devices in Spain from 2007 to 2020.
Direct oral anticoagulants: is it time to make the switch in cardiac surgery?
A meta-analysis of 4 clinical trials and 6 observational studies comparing the outcomes of direct oral anticoagulants (DOACs) with vitamin K antagonists (VKAs) in patients with atrial fibrillation (AF) carrying a bioprosthesis.
